Filer Snapshot

LAVA Medtech Acquisition Corp. SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0001855450.

Entity Type

Company

Total Filings

48

Latest Filing

09 Feb 2024

Industry

Blank Checks

Save this filer page for the next filing cycle

Keep this page in your research queue, then return to compare new filings with prior context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Best next steps

Start with the latest filings table, then open the strongest context page for this filer.

  • Use the filings table to verify the newest submission, form type, and report period.
  • Open the deeper context page only when this filer actually has insider or ownership signal.
Source: SEC Schedule 13D/G

SC 13G/A filed on 09 Feb 2024 for CIK 0001855450.

View Source Filing
Business address
303 Wyman St Ste 300, Waltham, MA, 02451
State of incorporation
DE
Fiscal year end
31 December

Quick Takeaways

  • LAVA Medtech Acquisition Corp. is an SEC filer tracked under CIK 0001855450.
  • 48 filings are listed on this profile.
  • Common form coverage includes SC 13G/A, 15-12G, 25-NSE and more.

What Changed

  • Latest filing: SC 13G/A filed on 09 Feb 2024.
  • Report period: not specified in filing header.

Why This Matters

  • You can quote filing dates and form types directly from the SEC record on this page.
  • Use this profile before deeper ownership or insider analysis to confirm filing history context.

Source Evidence

Source: SEC Schedule 13D/G

SC 13G/A filed on 09 Feb 2024 for CIK 0001855450.

View Source Filing

Return Loop

Why revisit this filer page

A newly filed SC 13G/A can change the filing history, ownership context, or next research path for LAVA Medtech Acquisition Corp..

Latest source-backed update
SC 13G/A filed 09 Feb 2024
Why come back
Revisit after a new SEC filing appears to compare the updated record with prior filings.
  • Latest filing on record: SC 13G/A filed 09 Feb 2024.
  • Save this filer if you want a stable place to return after the next filing cycle.
  • Open the latest filing table or ownership context to verify what changed.

Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.

Latest update

What changed recently for LAVA Medtech Acquisition Corp.

New fact period available

Latest financial period: Q4 2022. Open the source-backed page to inspect the fresh filing or facts context.

Update date

30 Mar 2023

Page type

Company facts

Latest period

Q4 2022

SEC-backed company facts were refreshed from filings filed on 30 Mar 2023.

Benchmark Context

Benchmark context for this company

LAVA Medtech Acquisition Corp. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest financial period: Q4 2022. That gives you a fresh baseline before you compare this company with peers.

  • Latest company facts filing date: 30 Mar 2023.
  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Company intelligence

Research LAVA Medtech Acquisition Corp. from filings to ownership signals

Use this company page as the hub for SEC filings, fundamentals, insider activity, large-stake holders, and institutional ownership context.

Active modules

3/5

Available company intelligence paths on this page.

Filings

48

SEC submissions provide the evidence trail.

Ownership context

1/3

Insider, large-stake, and institutional ownership lanes.

Return loop

Watch

Save the company so the next source-backed change has a clear place to bring you back.

Best-of company intelligence workflow

What changed?

Start with the latest filing and active ownership modules before opening older table rows.

Why might it matter?

Use insider, 13D/G, and 13F context to separate routine filings from ownership signals.

Where is evidence?

Keep SEC source documents one click away through filings, facts, insider reports, and Schedule 13D/G records.

What to watch next?

Save the company so watchlists can bring you back when the next filing-backed update lands.

SEC-verifiable company research path

Every company hub should answer what changed, why ownership activity might matter, where SEC evidence lives, and which filer, insider, holder, or filing page deserves the next click.

SEC filings

Available

Latest company filings

Start with the filing timeline to verify the newest source document and report period.

Open filings table

Company facts

Available

Financial context

Use XBRL facts when ownership activity needs revenue, earnings, debt, or cash-flow context.

Open company facts

Forms 3/4/5

Available

Insider activity

Check whether directors, officers, or 10% owners are buying, selling, or filing fresh ownership changes.

Open insider activity

Schedule 13D/G

Explore

Large-stake holders

Review beneficial ownership filings for activist-style or passive large holder changes around this issuer.

Browse large-stake radar

Form 13F

Explore

Institutional holders

Compare manager filings and smart-money context when company-level ownership needs broader holders.

Browse smart-money dashboard

SEC-verifiable company hub

The strongest research path is the one that keeps source documents close: filings first, then ownership signals, insider context, and fundamentals.

Create free account to watch this company

Watchlist return triggers

Watch LAVA Medtech Acquisition Corp. when any filing-backed ownership signal appears, then jump back into the exact SEC evidence path.

new company filing insider Form 4 13D/G holder change 13F holder update

Filer Overview

LAVA Medtech Acquisition Corp. has filed 48 SEC EDGAR filings since 29 Apr 2021. Common forms include SC 13G/A, 15-12G, 25-NSE, 8-K and more.

Latest Filings

Recent SEC filings for LAVA Medtech Acquisition Corp. with direct links to document and filing folders.

Form type Document Filing Description Filing date Reporting date File number(s)
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A FORM SC 13G/A 09 Feb 2024 005-93009
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A AMENDMENT NO. 2 10 Jan 2024 005-93009
15-12G Open 15-12G document View SEC filing for 15-12G FORM 15-12G 15 May 2023 001-40965
25-NSE Open 25-NSE document View SEC filing for 25-NSE 12 May 2023 333-259983
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 10 May 2023 10 May 2023 001-40965
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 01 May 2023 25 Apr 2023 001-40965
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K CURRENT REPORT 18 Apr 2023 18 Apr 2023 001-40965
DEF 14A Open DEF 14A document View SEC filing for DEF 14A DEF 14A 10 Apr 2023 25 Apr 2023 001-40965
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K ANNUAL REPORT 30 Mar 2023 31 Dec 2022 001-40965
PRE 14A Open PRE 14A document View SEC filing for PRE 14A PRE 14A 27 Mar 2023 27 Mar 2023 001-40965
SC 13G Open SC 13G document View SEC filing for SC 13G 14 Feb 2023 005-93009
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 13 Feb 2023 005-93009
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A AMENDMENT NO. 1 13 Feb 2023 005-93009
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 14 Nov 2022 30 Sep 2022 001-40965
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 15 Aug 2022 30 Jun 2022 001-40965
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q QUARTERLY REPORT 16 May 2022 31 Mar 2022 001-40965
SC 13G Open SC 13G document View SEC filing for SC 13G FORM SC 13G 13 May 2022 005-93009
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K ANNUAL REPORT 05 Apr 2022 31 Dec 2021 001-40965
NT 10-K Open NT 10-K document View SEC filing for NT 10-K NOTIFICATION OF LATE FILING 01 Apr 2022 31 Dec 2021 001-40965
SC 13G Open SC 13G document View SEC filing for SC 13G SCHEDULE 13G 14 Feb 2022 005-93009
SC 13G Open SC 13G document View SEC filing for SC 13G 11 Feb 2022 005-93009
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A 11 Feb 2022 005-93009
SC 13G Open SC 13G document View SEC filing for SC 13G FORM SC 13G 09 Feb 2022 005-93009
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K FORM 8-K 16 Dec 2021 16 Dec 2021 001-40965
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q FORM 10-Q 10 Dec 2021 30 Sep 2021 001-40965
SC 13G Open SC 13G document View SEC filing for SC 13G 08 Nov 2021 005-93009
8-K Open 8-K document View SEC filing for 8-K FORM 8-K 04 Nov 2021 29 Oct 2021 001-40965
8-K Open 8-K document View SEC filing for 8-K FORM 8-K 01 Nov 2021 26 Oct 2021 001-40965
424B4 Open 424B4 document View SEC filing for 424B4 424B4 28 Oct 2021 333-259983
EFFECT Open EFFECT document View SEC filing for EFFECT 26 Oct 2021 333-259983
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 26 Oct 2021 26 Oct 2021
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 26 Oct 2021 26 Oct 2021
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 26 Oct 2021 26 Oct 2021
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 26 Oct 2021 26 Oct 2021
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 26 Oct 2021 26 Oct 2021
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 26 Oct 2021 26 Oct 2021
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 26 Oct 2021 26 Oct 2021
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 26 Oct 2021 26 Oct 2021
CERT Open CERT document View SEC filing for CERT 26 Oct 2021 001-40965
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 25 Oct 2021 001-40965
CORRESP Open CORRESP document View SEC filing for CORRESP 22 Oct 2021
CORRESP Open CORRESP document View SEC filing for CORRESP 22 Oct 2021
CORRESP Open CORRESP document View SEC filing for CORRESP 15 Oct 2021
S-1/A Open S-1/A document View SEC filing for S-1/A S-1/A 15 Oct 2021 333-259983
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 08 Oct 2021
S-1 Open S-1 document View SEC filing for S-1 S-1 01 Oct 2021 333-259983
DRS/A Open DRS/A document View SEC filing for DRS/A 23 Aug 2021 377-04752
DRS Open DRS document View SEC filing for DRS 29 Apr 2021 377-04752

About this filer

LAVA Medtech Acquisition Corp. files with the SEC under CIK 0001855450. This page aggregates EDGAR filings and related ownership activity.

Industry: Blank Checks.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .